Lesley Baerts

1.1k total citations
17 papers, 851 citations indexed

About

Lesley Baerts is a scholar working on Oncology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lesley Baerts has authored 17 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lesley Baerts's work include Peptidase Inhibition and Analysis (13 papers), Neuropeptides and Animal Physiology (8 papers) and Diabetes Treatment and Management (7 papers). Lesley Baerts is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Neuropeptides and Animal Physiology (8 papers) and Diabetes Treatment and Management (7 papers). Lesley Baerts collaborates with scholars based in Belgium, Switzerland and Germany. Lesley Baerts's co-authors include Ingrid De Meester, Veerle Matheeussen, Yannick Waumans, Anne‐Marie Lambeir, Wolfgang Jungraithmayr, Walter Weder, Patrick C. D’Haese, Anja Verhulst, Kirsten Maertens and Elke Leuridan and has published in prestigious journals such as PLoS ONE, Arteriosclerosis Thrombosis and Vascular Biology and Frontiers in Immunology.

In The Last Decade

Lesley Baerts

17 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Baerts Belgium 15 375 355 210 189 143 17 851
Norihito Watanabe Japan 17 250 0.7× 217 0.6× 204 1.0× 24 0.1× 463 3.2× 94 1.4k
V. Bonnevie‐Nielsen Denmark 17 90 0.2× 279 0.8× 309 1.5× 33 0.2× 269 1.9× 39 1.1k
N. Rizzo Italy 25 113 0.3× 60 0.2× 114 0.5× 34 0.2× 403 2.8× 69 1.7k
Lilia Goudeva Germany 21 366 1.0× 87 0.2× 196 0.9× 16 0.1× 57 0.4× 35 1.1k
S Caponnetto Italy 19 485 1.3× 109 0.3× 307 1.5× 14 0.1× 161 1.1× 85 1.2k
Karin Müller Germany 18 91 0.2× 51 0.1× 149 0.7× 58 0.3× 230 1.6× 59 1.0k
June Ye United States 12 95 0.3× 524 1.5× 288 1.4× 20 0.1× 197 1.4× 17 975
Jason Robarge United States 14 289 0.8× 70 0.2× 246 1.2× 13 0.1× 72 0.5× 26 1.0k
Pamela Bowman United Kingdom 16 253 0.7× 328 0.9× 221 1.1× 8 0.0× 481 3.4× 28 1.1k
Mi Na Kim South Korea 21 110 0.3× 90 0.3× 126 0.6× 20 0.1× 92 0.6× 75 1.2k

Countries citing papers authored by Lesley Baerts

Since Specialization
Citations

This map shows the geographic impact of Lesley Baerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Baerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Baerts more than expected).

Fields of papers citing papers by Lesley Baerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Baerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Baerts. The network helps show where Lesley Baerts may publish in the future.

Co-authorship network of co-authors of Lesley Baerts

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Baerts. A scholar is included among the top collaborators of Lesley Baerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Baerts. Lesley Baerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sternkopf, Marieke, Magdolna Nagy, Constance C. F. M. J. Baaten, et al.. (2020). Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions. Arteriosclerosis Thrombosis and Vascular Biology. 40(3). e65–e77. 26 indexed citations
2.
Baerts, Lesley, Raf Brouns, Robert Verkerk, et al.. (2016). Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity. Translational Stroke Research. 8(2). 157–164. 19 indexed citations
3.
Jang, Jae–Hwi, Yoshito Yamada, Ingrid De Meester, et al.. (2016). Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin. Journal of Thoracic and Cardiovascular Surgery. 153(3). 713–724.e4. 14 indexed citations
4.
Baerts, Lesley, Yannick Waumans, Inger Brandt, et al.. (2015). Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling. PLoS ONE. 10(11). e0141408–e0141408. 16 indexed citations
5.
Maertens, Kirsten, et al.. (2015). Quantification of Vaccine-induced Antipertussis Toxin Secretory IgA Antibodies in Breast Milk. The Pediatric Infectious Disease Journal. 34(6). e149–e152. 34 indexed citations
6.
Jang, Jae–Hwi, Lesley Baerts, Yannick Waumans, et al.. (2015). Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. Clinical & Experimental Metastasis. 32(7). 677–687. 61 indexed citations
7.
Baerts, Lesley, Walid Maho, Anja Verhulst, et al.. (2015). Potential impact of sitagliptin on collagen-derived dipeptides in diabetic osteoporosis. Pharmacological Research. 100. 336–340. 11 indexed citations
9.
Yamada, Yoshito, Jae–Hwi Jang, Ingrid De Meester, et al.. (2015). CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression. The Journal of Heart and Lung Transplantation. 35(4). 508–517. 33 indexed citations
10.
Maertens, Kirsten, Tessa Braeckman, Lesley Baerts, et al.. (2014). Breastfeeding after maternal immunisation during pregnancy: Providing immunological protection to the newborn: A review. Vaccine. 32(16). 1786–1792. 64 indexed citations
11.
Behets, Geert J., et al.. (2014). DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats. American Journal of Physiology-Endocrinology and Metabolism. 307(5). E447–E455. 60 indexed citations
12.
Hamdani, Nazha, Anne-Sophie Hervent, Veerle Matheeussen, et al.. (2014). Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4. Cardiovascular Research. 104(3). 423–431. 63 indexed citations
13.
Baerts, Lesley, Nelson Gomez, Marc Vanderheyden, Ingrid De Meester, & Kathleen Mc Entee. (2012). Possible mechanisms for brain natriuretic peptide resistance in heart failure with a focus on interspecies differences and canine BNP biology. The Veterinary Journal. 194(1). 34–39. 11 indexed citations
14.
Verhulst, Anja, Veerle Matheeussen, Lesley Baerts, et al.. (2012). DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology. 303(5). F681–F688. 84 indexed citations
15.
Gomez, Nelson, Veerle Matheeussen, Maryam Mahmoudabady, et al.. (2011). Dipeptidyl Peptidase IV Inhibition Improves Cardiorenal Function in Overpacing-Induced Heart Failure. European Journal of Heart Failure. 14(1). 14–21. 91 indexed citations
16.
Matheeussen, Veerle, Lesley Baerts, Guido R.Y. De Meyer, et al.. (2011). Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biological Chemistry. 392(3). 189–98. 59 indexed citations
17.
Jungraithmayr, Wolfgang, Ingrid De Meester, Veerle Matheeussen, et al.. (2011). CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. European Journal of Cardio-Thoracic Surgery. 41(5). 1166–1173. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026